Is nationwide special campaign on antibiotic stewardship program effective on ameliorating irrational antibiotic use in China? Study on the antibiotic use of specialized hospitals in China in 2011–2012

  • Xiao-xu Zou (邹晓旭)
  • Zi Fang (方 子)
  • Rui Min (闵 锐)
  • Xue Bai (白 雪)
  • Yang Zhang (张 杨)
  • Dong Xu (许 栋)
  • Peng-qian Fang (方鹏骞)Email author


With dwindling number of new antibiotics and inappropriate use of antibiotics, the emergence and spread of antibiotics resistance occurs commonly in healthcare institutions worldwide. In China, antibiotics are commonly overprescribed and misused. This study is to assess the effect of the nationwide special campaign on antibiotic stewardship program (ASP) at specialized hospitals in China by investigating prescription information from 2011 to 2012. Data on the hospital consumption and prescription of systemic antibiotics were obtained from four specialized hospitals, including maternity, children’s, stomatological and cancer hospitals. Systematic random sampling was used to select outpatient prescriptions and inpatient cases. A total of 105 specialized hospitals in 2011 and 121 specialized hospitals in 2012 were analysed. The defined daily doses (DDDs) per 100 inpatient days, the percentage of antibiotic use in outpatient prescriptions, and the percentage of antibiotic use in inpatient cases were used as measurements of antibiotic use. The overall antibiotic use density in the selected hospitals decreased between 2011 and 2012 from 39.37 to 26.54 DDD/100 inpatient days (P<0.001). The percentage of antibiotic use in outpatient prescriptions (range: 24.12%–18.71%, P=0.109) and inpatient cases (64.85%–60.10%, P=0.006) also decreased within the two years. Significant changes were observed among regions and different hospitals within the two years. And antibiotic consumption was correlated with the type and size of specialized hospital in 2012, but not with the regions. This analysis of antibiotic consumption of specialized hospitals allows relevant comparisons for benchmarking and shows that national ASP has improved antibiotic rational use in China. The data will assist policymakers in formulating effective strategies to decrease antibiotic overuse and identify areas that require further work.

Key words

specialized hospital antibiotic usage antibiotic prescription national antibiotic stewardship program, China 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Klugman KP, Koornhof HJ. Worldwide increase in pneumococcal antibiotic resistance. Lancet, 1989,2(8660): 444PubMedCrossRefGoogle Scholar
  2. 2.
    Hawkey PM. Action against antibiotic resistance: no time to lose. Lancet, 1998,351(9112):1298–1299PubMedCrossRefGoogle Scholar
  3. 3.
    Dong L, Yan H, Wang D. Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. J Antimicrob Chemother, 2008, 62(2):410–415PubMedCrossRefGoogle Scholar
  4. 4.
    Ferber D. Antibiotic resistance. Superbugs on the hoof? Science, 2000, 288(5467):792–794PubMedCrossRefGoogle Scholar
  5. 5.
    Kmietowicz Z. WHO warns of threat of “superbugs”. BMJ, 2000, 320(7250):1624PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy Plan, 1999, 14(2):89–102PubMedCrossRefGoogle Scholar
  7. 7.
    Phelps CE. Bug/drug resistance. Sometimes less is more. Med Care, 1989, 27(2):194–203PubMedCrossRefGoogle Scholar
  8. 8.
    Zhang R, Eggleston K, Rotimi V, et al. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health, 2006, 2:6PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    World Health Organization. The evolving threat of antimicrobial resistance: Options for action. World Health Organization, 2012Google Scholar
  10. 10.
    Tang S, Meng Q, Chen L, et al. Tackling the challenges to health equity in China. Lancet, 2008, 372(9648): 1493–1501PubMedCrossRefGoogle Scholar
  11. 11.
    Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet, 2012, 379(9818):805–814PubMedCrossRefGoogle Scholar
  12. 12.
    Kondro W. Canadian scientists urge government to develop antibiotic plan. Lancet, 2002, 360(9341):1230PubMedCrossRefGoogle Scholar
  13. 13.
    de Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet, 2000, 355(9208):973–978PubMedCrossRefGoogle Scholar
  14. 14.
    Schito GC, Debbia EA, Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother, 2000, 46(Suppl T1):3–9PubMedCrossRefGoogle Scholar
  15. 15.
    WHO, Ministry of Health in China. China-WHO Country Cooperation Strategy 2013-2015. World Health Organization, 2013Google Scholar
  16. 16.
    Chen W, Tang S, Sun J, et al. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Serv Res, 2010, 10:211PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Xiang X, Yang C, Wang D, et al. Effects of China’s national essential medicines policy on the use of injection in primary health facilities. J Huazhong Univ Sci Technolog Med Sci, 2012, 32(4):626–629PubMedCrossRefGoogle Scholar
  18. 18.
    Heddini A, Cars O, Qiang S, et al. Antibiotic resistance in China—a major future challenge. Lancet, 2009, 373(9657):30PubMedCrossRefGoogle Scholar
  19. 19.
  20. 20.
    Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy, 2009, 90(1):32–36PubMedCrossRefGoogle Scholar
  21. 21.
    Bi P, Tong S, Parton KA. Family self-medication and antibiotics abuse for children and juveniles in a Chinese city. Soc Sci Med, 2000, 50(10):1445–1450PubMedCrossRefGoogle Scholar
  22. 22.
    Ramanan Laxminarayan AMDH. Extending the cure: policy responses to the growing threat of antibiotic resistance. Washington, DC 20036-1400 USA: 2007Google Scholar
  23. 23.
    Ministry of Health in China. Interim provisions on the administration of hospital pharmacy. 2002. (Chinese)Google Scholar
  24. 24.
    Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet Infect Dis, 2013, 13(3):189–191PubMedCrossRefGoogle Scholar
  25. 25.
    Yang L, Liu C, Ferrier JA, et al. The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy Plan, 2012Google Scholar
  26. 26.
    Ministry of Health in China. Notification for the special campaign of antibiotics rational use in hospitals. 2012. (Chinese)Google Scholar
  27. 27.
    Regev-Yochay G, Raz M, Dagan R, et al. Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis, 2011, 53(1):33–41PubMedCrossRefGoogle Scholar
  28. 28.
    Kern WV, de With K, Nink K, et al. Regional variation in outpatient antibiotic prescribing in Germany. Infection, 2006, 34(5):269–273PubMedCrossRefGoogle Scholar
  29. 29.
    Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy, 2006, 78(1):77–92PubMedCrossRefGoogle Scholar
  30. 30.
    National Bureau of Statistics in China. The Divide of Regions According to Economic Development in China. 2012. (Chinese)Google Scholar
  31. 31.
    National Bureau of Statistics in China. Division Method of Regions. 2011. (Chinese)Google Scholar
  32. 32.
    Antachopoulos C, Dotis J, Pentsioglou V. Development of a paediatric daily defined dose system for the measurement of antibiotic consumption in paediatric units. 14th European Congress of Clinical Microbiology and Infectious Diseases. Prague, Czech Republic: 2004Google Scholar
  33. 33.
    Kern WV, de With K, Steib-Bauert M, et al. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001–2002. Infection, 2005, 33(5–6):333–339PubMedCrossRefGoogle Scholar
  34. 34.
    De WK, Steib-Bauert M, Straach P, et al. Is there significant regional variation in hospital antibiotic consumption in Germany? Infection, 2006, 34(5):274–277CrossRefGoogle Scholar
  35. 35.
    Piovani D, Clavenna A, Cartabia M, et al. The regional profile of antibiotic prescriptions in Italian outpatient children. Eur J Clin Pharmacol, 2012, 68(6):997–1005PubMedCrossRefGoogle Scholar
  36. 36.
    Zhang W, Shen X, Bergman U, et al. Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese children’s hospitals (2002–2006). Int J Antimicrob Agents, 2008, 32(3):250–255PubMedCrossRefGoogle Scholar
  37. 37.
    Ceyhan M, Yildirim I, Ecevit C, et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis, 2010, 14(1): e55–e61PubMedCrossRefGoogle Scholar
  38. 38.
    Ashiru-Oredope D, Sharland M, Charani E, et al. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart—Then Focus. J Antimicrob Chemother, 2012, 67(Suppl 1):i51–i63PubMedCrossRefGoogle Scholar
  39. 39.
    Low M, Nitzan O, Bitterman H, et al. Trends in outpatient antibiotic use in Israel during the years 2000–2010: setting targets for an intervention. Infection, 2013, 41(2): 401–407PubMedCrossRefGoogle Scholar
  40. 40.
    Cairns KA, Jenney AW, Abbott IJ, et al. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust, 2013, 198(5): 262–266PubMedCrossRefGoogle Scholar
  41. 41.
    Dumartin C, Rogues AM, Amadeo B, et al. Antibiotic stewardship programmes: legal framework and structure and process indicator in Southwestern French hospitals, 2005–2008. J Hosp Infect, 2011, 77(2):123–128PubMedCrossRefGoogle Scholar
  42. 42.
    Hadi U, Keuter M, van Asten H, et al. Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital. Trop Med Int Health, 2008, 13(7):888–899PubMedCrossRefGoogle Scholar
  43. 43.
    Wilf-Miron R, Ron N, Ishai S, et al. Reducing the volume of antibiotic prescriptions: a peer group intervention among physicians serving a community with special ethnic characteristics. J Manag Care Pharm, 2012, 18(4): 324–328PubMedGoogle Scholar
  44. 44.
    Elseviers MM, Ferech M, Vander SR, et al. Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf, 2007, 16(1):115–123PubMedCrossRefGoogle Scholar
  45. 45.
    Dumartin C, L’Heriteau F, Pefau M, et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother, 2010, 65(9):2028–2036PubMedCrossRefGoogle Scholar
  46. 46.
    Grau S, Fondevilla E, Mojal S, et al. Antibiotic consumption at 46 VINCat hospitals from 2007 to 2009, stratified by hospital size and clinical services. Enferm Infecc Microbiol Clin, 2012, 30(Suppl 3):43–51PubMedCrossRefGoogle Scholar
  47. 47.
    D’Alerte R. Surveillance de la consommation des antibiotiques. Institut de veille sanitaire, 2010Google Scholar
  48. 48.
    Sumpradit N, Chongtrakul P, Anuwong K, et al. Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ, 2012, 90(12):905–913PubMedCentralPubMedGoogle Scholar
  49. 49.
    Stockley JM. European Antibiotic Awareness Day 2012: getting smart about antibiotics, a public-professional partnership. J Infect, 2012, 65(5):377–379PubMedCrossRefGoogle Scholar
  50. 50.
    Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: Evidence from an audit study in China. J Health Econ, 2011, 30(5):933–949PubMedCrossRefGoogle Scholar
  51. 51.
    Goossens H, Ferech M, Vander SR, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 2005, 365(9459): 579–587PubMedCrossRefGoogle Scholar
  52. 52.
    Kuster SP, Ruef C, Bollinger AK, et al. Correlation between case mix index and antibiotic use in hospitals. J Antimicrob Chemother, 2008, 62(4):837–842PubMedCrossRefGoogle Scholar
  53. 53.
    Sabath LD, Notto DA. Analysis of factors influencing antibiotic usage in hospitals. Prog Clin Biol Res, 1979, 35:65–74PubMedGoogle Scholar

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Xiao-xu Zou (邹晓旭)
    • 1
  • Zi Fang (方 子)
    • 2
    • 3
  • Rui Min (闵 锐)
    • 1
  • Xue Bai (白 雪)
    • 1
  • Yang Zhang (张 杨)
    • 4
  • Dong Xu (许 栋)
    • 5
  • Peng-qian Fang (方鹏骞)
    • 1
    Email author
  1. 1.School of Medicine and Health Management, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  2. 2.School of Foreign Languages and LiteratureWuhan UniversityWuhanChina
  3. 3.School of BusinessUniversity of AberdeenAberdeenUK
  4. 4.Department of Pharmacy, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  5. 5.Management Research Institute, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations